A Study of HMPL-306 in Advanced Solid Tumors With IDH Mutations
Hutchmed
Hutchmed
Exelixis
Incyte Corporation
Novartis
Ikena Oncology
Kintara Therapeutics, Inc.
Alaunos Therapeutics
Ourotech, Inc.
Jazz Pharmaceuticals
Regeneron Pharmaceuticals
Dawonmedax Co., Ltd.
Jazz Pharmaceuticals
Aminex Therapeutics, Inc.
Bexion Pharmaceuticals, Inc.
Bexion Pharmaceuticals, Inc.
Amgen
OncoSynergy, Inc.
Nuvation Bio Inc.
Vanquish Oncology, Inc.
Bristol-Myers Squibb
Karyopharm Therapeutics Inc
Xennials Therapeutics Australia Pty Ltd
Boston Scientific Corporation
Boston Scientific Corporation
Boston Scientific Corporation
Polaris Group
Tocagen Inc.
Pfizer
Arog Pharmaceuticals, Inc.
Cellectar Biosciences, Inc.
Isarna Therapeutics GmbH
Gilead Sciences
Keryx / AOI Pharmaceuticals, Inc.
Novartis
Diffusion Pharmaceuticals Inc